|Title||Lymphoid malignancy 2|
By the end of the training period trainees will, in respect of lymphoid malignancy* be able to:
- analyse, synthesise, evaluate and apply knowledge
- perform, adapt and master a range of technical and clinical skills and procedures and
- demonstrate the attitudes and behaviours necessary for professional practice as a consultant clinical scientist dealing with the complexities, uncertainties and tensions of professional practice at this level.
Diagnosis and liaison for lymphoma and thymoma
Asynchronous expression of markers (e.g. CD19,5).
Knowledge and understanding
By the end of the training period the trainee will be able to demonstrate the ability to analyse, evaluate and synthesise relevant knowledge and its application to their professional practice in relation to:
- appropriate laboratory investigations
- therapeutic interventions:
- putative mechanisms of action of various immunological therapies
- principles of the various therapeutic options to guide the most appropriate treatment for an individual patient
- a working knowledge of the evidence base for the use of various immunological therapies
- the diagnosis and clinical liaison for myeloma / lymphoid malignancy.
Technical and clinical skills
By the end of the training period the trainee will be able to apply knowledge of lymphoid malignancy to direct a diagnostic immunology laboratory to perform, adapt and master the clinical skills necessary to manage:
- therapeutic options and understanding of the principles of their actions to aid clinical decision making
- strategies to diagnose and monitor immunological diseases
- diagnosis and clinical liaison for drug induced ID (anticonvulsant, corticosteroids, DMARDS), hypercatabolism and protein loss, thymoma and auto immune cytokine deficiencies.
- be familiar with national guidance on appropriate test selection and use where relevant, e.g. NICE.
Attitudes and behaviours
This module has no attitude and behaviours information.